5Definitions

5 Definitions

Note 1: A number of expressions used in this Determination are defined in the Act, including the following:

(a) pharmacist (see subsection 4(1) of the Act);
(b) premises (see subsection 4(1) of the Act);
(c) prescription for the supply of a pharmaceutical benefit (see subsection 4(2) of the Act);
(d) supply of pharmaceutical benefits at premises (see subsection 4(3) of the Act).

Note 2: Under subsection 4(1A) of the Act, a word or phrase defined for the purposes of the Health Insurance Act 1973 has the meaning that it would have if used in that Act. The expression National Law used in this instrument is defined in that Act.

In this determination:

Act means the National Health Act 1953.

approval number, for an approved pharmacist in respect of particular premises, means the pharmacist’s approval number under section 16 of the Regulations in respect of those premises.

approved pharmacist has the same meaning as in Part VII of the Act.

approved premises for an approved pharmacist means premises in respect of which the pharmacist is approved for the purposes of Part VII of the National Health Act 1953.

arrangement includes a contract, agreement or understanding, written or oral, and whether or not legally enforceable.

brand has the same meaning as in Part VII of the Act.

continued dispensing prescription, for a supply of a pharmaceutical benefit in accordance with subsection 89A(1) of the Act (supply without prescription), means the prescription referred to section 3.03 of the National Health (Continued Dispensing) Determination 2022 in relation to the supply.

deferred supply authorisation has the same meaning as in the Regulations.

dispensing step: each of the following is a dispensing step in the dispensing of a pharmaceutical benefit:

(a) if the benefit is to be supplied on the basis of a prescription (other than a medication chart prescription), repeat authorisation or deferred supply authorisation—reviewing the prescription, repeat authorisation or deferred supply authorisation;
(b) if any of the following apply to the benefit—preparing the benefit:
(i) the benefit is a listed brand of a pharmaceutical item and the quantity of the benefit is less than a pack quantity of the listed brand of the pharmaceutical item;
(ii) the benefit requires the admixture of ready‑prepared ingredients;
(iii) the benefit is an extemporaneously‑prepared pharmaceutical benefit;
(c) if the benefit is to be supplied other than on an order lodged under section 33 of the Regulations (prescriber bag supplies)—generating, and affixing to the packaging for the benefit, a label that displays the following:
(i) for a benefit other than an extemporaneously‑prepared pharmaceutical benefit or a benefit that is to be supplied in accordance with the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024—the brand of the pharmaceutical item in the benefit;
(ii) if paragraph 40(2A)(b) or 41(2A)(b) of the Regulations applied to the prescription or continued dispensing prescription for the supply of the benefit—each drug that the benefit has;
(iii) the form (if any) and quantity or number of units of the benefit;
(iv) directions for use of the benefit in accordance with the instructions of the PBS prescriber who wrote the prescription or continued dispensing prescription for the supply of the benefit;
(v) the name of the person for whom the prescription or continued dispensing prescription for the supply of the benefit was written;
(vi) the date the benefit is dispensed;
(vii) the address of the premises at which the benefit is dispensed;
(viii) the name of the pharmacy situated at those premises (the dispensing pharmacy);
(ix) if subsection 64(1) of the Regulations applies to the benefit—the full cost of the benefit;
(d) if required by section 52 of the Regulations—preparing a repeat authorisation for the benefit;
(e) recording the dispensing of the benefit in the dispensing pharmacy’s system for recording the dispensing of pharmaceutical benefits.